Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avidekel Oil
- Development stage
- Unknown
- Lead developer
- Tikun Olam
- Modality
- Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Avidekel Oil is a high-cannabidiol (CBD) medical cannabis oil formulation developed by Tikun Olam. It is derived from the proprietary Avidekel cannabis strain, which is characterized by a high CBD-to-THC ratio (typically 30:1), ensuring therapeutic effects without significant psychoactivity. The oil is primarily investigated for managing behavioral and psychological symptoms of dementia (BPSD), such as agitation, aggression, and sleep disturbances in patients with Alzheimer's disease. Its mechanism of action involves the modulation of the endocannabinoid system through cannabinoid receptors (CB1 and CB2) and interactions with non-cannabinoid targets, including the serotonin 5-HT1A receptor and the TRPV1 cation channel, which contribute to its calming, anti-inflammatory, and neuroprotective properties.
- Brand names
- Avidekel Oil
- Other names
- Avidekel
02
Targets
CNR2 (Cannabinoid receptor type 2)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Avidekel Oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avidekel Oil.